11-33768958-G-C
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The ENST00000526785.5(FBXO3):c.-89C>G variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.00000958 in 1,461,440 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000526785.5 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251252Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135798
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461440Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 727036
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.251C>G (p.S84C) alteration is located in exon 3 (coding exon 3) of the FBXO3 gene. This alteration results from a C to G substitution at nucleotide position 251, causing the serine (S) at amino acid position 84 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at